Jyong Biotech MENS
NASDAQ MENS
$1.77 +0.03 (+1.72%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Ending Cash Balance (2024 - 2025)

Updated

Analysis

Jyong Biotech (MENS) Ending Cash Balance (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 16.91 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.03 Bn
10 Jyong Biotech 129.23 Mn 129.23 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.18 Mn
Dec 31, 2024 101,000.00
API Access

Jyong Biotech Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=MENS&period=max&api_key=YOUR_API_KEY